author-photo

A. Lohri

Praxis

12

Papers

1907

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 By the German Hodgkin Study Group

2018 Blood
Show All
- Source
- Cite
- Save
Citations (10)
An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma

2013 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (35)
Comparing long-term toxicity and efficacy of combined modality treatment including extended- or involved-field radiotherapy in early-stage Hodgkin's lymphoma

2012 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (31)
Dose-Intensified Combined Modality Treatment with 2 Cycles of BEACOPP Escalated Followed by 2 Cycles of ABVD and IF-RT in Patients with Early Unfavourable Hodgkin Lymphoma (HL): An Analysis of the German Hodgkin Study Group (GHSG) HD14 Trial

2008 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group

2006 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (54)
Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly × 4 schedule

2004 Blood
Show All
- Source
- Cite
- Save
Citations (528)
The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK).

2000 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (68)
The effect of Rituximab on patients with follicular and mantle-cell lymphoma

2000 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (106)
High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemias

1994 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (72)
FACTOR XII, PLASMA PREKALLIKREIN ,α2-MACROGLOBULIN AND C1-INHIBITOR LEVELS IN RENAL ALLOGRAFT RECIPIENTS DURING IMMUNOSUPPRESSION WITH CYCLOSPORIN A

1987
Show All
- Source
- Cite
- Save
Citations (0)